Expand ENTA Menu
ENTA MENU

ENTA Stock Posts


ENTA #EnantaPharmaceuticals stock declines -12.3% in premarket,

Premarket Decliner

ENTA Enanta Pharmaceuticals11.97-3.19-21.0%

Premarket:10.50-1.47 (-12.3%)

Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Business WireTue, 30-Sep 9:00 PM

ENTA #EnantaPharmaceuticals stock declines -8.3% in after hours trading. See the latest news.

After Hours Decliner

ENTA Enanta Pharmaceuticals11.97-3.19-21.0%

After Hours:10.98-0.99 (-8.3%)

Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Business WireTue, 30-Sep 9:00 PM

ENTA #EnantaPharmaceuticals stock declines -8.7% in after hours trading. See the latest news.

After Hours Decliner

ENTA Enanta Pharmaceuticals11.97-3.19-21.0%

After Hours:10.93-1.04 (-8.7%)

Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock

Business WireTue, 30-Sep 4:11 PM

Unusual Option Volume

ENTA Enanta Pharmaceuticals11.89-3.27 (-21.6%)

Enanta Pharmaceuticals trades 2,201 contracts.
Unusual Option Volume

ENTA Enanta Pharmaceuticals12.71+4.81 (+60.9%)

Enanta Pharmaceuticals trades 2,287 contracts. The company has the following event: Conference Call and Webcast to Discuss Topline Results from Phase 2b Study Evaluating Zelicapavir for RSV in High-Risk Adults on Sep 29, 2025. News: Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
ENTA #EnantaPharmaceuticals stock increases 17.5% after hours.

After Hours Gainer

Market Data Delayed 15 Minutes